Clinical severity is typically assessed using the following benchmarks:
Moderate to severe chronic plaque psoriasis is an immune-mediated condition characterized by raised, red, scaly plaques covering more than 3% to 10% of the body surface area. While there is no cure, recent medical advancements—particularly in biologic therapies—have made clear or near-complete skin clearance a realistic clinical goal.
Psoriasis in high-impact areas like the face, hands, feet, or genitals is often classified as moderate to severe regardless of the total percentage of skin affected.
Moderate is often defined as 3%–10% involvement, while severe is more than 10%. One percent is roughly the size of your palm.
For moderate to severe cases, doctors typically move beyond topical creams to systemic treatments that work throughout the body.
Scoring high on the Dermatology Life Quality Index (DLQI)—typically a score over 10—can also trigger this classification. Review of Primary Treatment Options
